{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:23:43Z","timestamp":1773761023671,"version":"3.50.1"},"reference-count":15,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T00:00:00Z","timestamp":1315267200000},"content-version":"vor","delay-in-days":4845,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Rep Immunol"],"published-print":{"date-parts":[[1998,6]]},"abstract":"<jats:p>PROBLEMS: 1) Does the administration of heparin and aspirin (H\/A) in combination with intravenous immunoglobulin G (IVIG) improve <jats:italic>in vitro<\/jats:italic> fertilization (IVF) implantation and birth rates in patients with recurrent IVF failures? 2) Is the effect of such treatment related to the antiphospholipid antibody (APA) status of the patients concerned?<\/jats:p><jats:p>METHOD OF STUDY: Subjects consisted of 89 women younger than 36 years of age whose infertility was a result of causes other than male infertility and who had experienced four or more failed IVF\/embryo transfer procedures. Fifty\u2010two women were APA+ (group A), and 37 were APA\u2010 (group B). All patients, regardless of their APA status, received H\/A (5000 U sq bid), aspirin (81 mg po qd) from the inception of menotropin therapy along with IVIG (20 g) through a single infusion 3 to 10 days before egg retrieval.<\/jats:p><jats:p>RESULTS: Twenty\u2010two (42%) of group A and 7 (19%) of group B patients achieved live births (<jats:italic>P<\/jats:italic> = 0.020).<\/jats:p><jats:p>CONCLUSIONS: IVF outcome is significantly improved when H\/A and IVIG are administered to APA+ women with repeat IVF failures. APA\u2010 women do not seem to benefit from such treatment.<\/jats:p>","DOI":"10.1111\/j.1600-0897.1998.tb00375.x","type":"journal-article","created":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T11:49:05Z","timestamp":1315309745000},"page":"391-394","source":"Crossref","is-referenced-by-count":49,"title":["A Rational Basis for the Use of Combined Heparin\/Aspirin and IVIG Immunotherapy in the Treatment of Recurrent IVF Failure Associated with Antiphospholipid Antibodies"],"prefix":"10.1111","volume":"39","author":[{"given":"Geoffrey","family":"Sher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christo","family":"Zouves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghanima","family":"Maassarani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Feinman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Matzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penny","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendell","family":"Ching","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,9,6]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006254-199406000-00026"},{"key":"e_1_2_1_3_2","first-page":"433","article-title":"Antiphospholipid antibodies and pregnancy loss","volume":"33","author":"Rote NS","year":"1995","journal-title":"Am J Reprod Immunol"},{"key":"e_1_2_1_4_2","first-page":"286","article-title":"Treatment of autoimmune\u2010associated recurrent pregnancy loss with ASA and Heparin: A case series","volume":"32","author":"Stephenson MD","year":"1995","journal-title":"Am J Reprod Immunol"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(91)90695-N"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(94)70110-5"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1994.tb00848.x"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1996.tb00499.x"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a138437"},{"key":"e_1_2_1_10_2","article-title":"The selective use of heparin\/aspirin therapy, alone or in combination with intravenous immunoglobulin G in the management of antiphospholipid antibody positive women undergoing in vitro fertilization","author":"Sher G.","year":"1998","journal-title":"Am J Reprod Immunol"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a138435"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(97)81443-4"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a137312"},{"key":"e_1_2_1_14_2","first-page":"27","article-title":"Characterization of antiphospholipid antibodies in women with recurrent spontaneous abortions","volume":"39","author":"Matzner W.","year":"1994","journal-title":"J Reprod Med"},{"key":"e_1_2_1_15_2","unstructured":"KleinsteinJ. KhanagaO. GipsH. KunzelW.:Intravenous immunoglobulins increase clinical pregnancy rates in an IVF program. Proceedings of the 41st Annual Meeting of the Society for Investigative Gynecology 1994 abstract P108."},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1994.tb21751.x"}],"container-title":["American Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0897.1998.tb00375.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0897.1998.tb00375.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T10:47:53Z","timestamp":1698490073000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0897.1998.tb00375.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["10.1111\/j.1600-0897.1998.tb00375.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0897.1998.tb00375.x","archive":["Portico"],"relation":{},"ISSN":["1046-7408","1600-0897"],"issn-type":[{"value":"1046-7408","type":"print"},{"value":"1600-0897","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}